BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 30641775)

  • 1. Chronic kidney disease among US adults with type 2 diabetes and cardiovascular diseases: A national estimate of prevalence by KDIGO 2012 classification.
    Wang T; Xi Y; Lubwama R; Hannanchi H; Iglay K; Koro C
    Diabetes Metab Syndr; 2019; 13(1):612-615. PubMed ID: 30641775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study.
    Pugliese G; Solini A; Bonora E; Orsi E; Zerbini G; Fondelli C; Gruden G; Cavalot F; Lamacchia O; Trevisan R; Vedovato M; Penno G;
    Cardiovasc Diabetol; 2014 Mar; 13():59. PubMed ID: 24624891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging.
    Bailey RA; Wang Y; Zhu V; Rupnow MF
    BMC Res Notes; 2014 Jul; 7():415. PubMed ID: 24990184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of chronic kidney disease on the prevalence of cardiovascular disease in patients with type 2 diabetes in Spain: PERCEDIME2 study.
    Rodriguez-Poncelas A; Coll-De Tuero G; Turrò-Garriga O; Barrot-de la Puente J; Franch-Nadal J; Mundet-Tuduri X;
    BMC Nephrol; 2014 Sep; 15():150. PubMed ID: 25227555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Light wine consumption is associated with a lower odd for cardiovascular disease in chronic kidney disease.
    Jespersen T; Kruse N; Mehta T; Kuwabara M; Noureddine L; Jalal D
    Nutr Metab Cardiovasc Dis; 2018 Nov; 28(11):1133-1139. PubMed ID: 30143406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care.
    Metsärinne K; Bröijersen A; Kantola I; Niskanen L; Rissanen A; Appelroth T; Pöntynen N; Poussa T; Koivisto V; Virkamäki A;
    Prim Care Diabetes; 2015 Feb; 9(1):31-8. PubMed ID: 25066820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cardiovascular disease burden and therapeutic goal attainment in US adults with chronic kidney disease: an analysis of national health and nutritional examination survey data, 2001-2010.
    Kuznik A; Mardekian J; Tarasenko L
    BMC Nephrol; 2013 Jun; 14():132. PubMed ID: 23802885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adults.
    Schechter M; Melzer Cohen C; Yanuv I; Rozenberg A; Chodick G; Bodegård J; Leiter LA; Verma S; Lambers Heerspink HJ; Karasik A; Mosenzon O
    Cardiovasc Diabetol; 2022 Jun; 21(1):104. PubMed ID: 35689214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020.
    Ostrominski JW; Arnold SV; Butler J; Fonarow GC; Hirsch JS; Palli SR; Donato BMK; Parrinello CM; O'Connell T; Collins EB; Woolley JJ; Kosiborod MN; Vaduganathan M
    JAMA Cardiol; 2023 Nov; 8(11):1050-1060. PubMed ID: 37755728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular and Renal Outcomes in Patients with Type-2 Diabetes and Chronic Kidney Disease Identified in a United States Administrative Claims Database: A Population Cohort Study.
    Folkerts K; Kelly AMB; Petruski-Ivleva N; Fried L; Blankenburg M; Gay A; Velentgas P; Kovesdy CP
    Nephron; 2021; 145(4):342-352. PubMed ID: 33789294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium-glucose transporter 2 inhibitors for renal and cardiovascular protection in US adults with type 2 diabetes: Impact of the 2020 KDIGO clinical practice guidelines.
    Ciardullo S; Trevisan R; Perseghin G
    Pharmacol Res; 2021 Apr; 166():105530. PubMed ID: 33675963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of chronic kidney disease in the Netherlands and its cardiovascular and renal complications.
    Vervloet MG; de Jong HJ; Pander J; Overbeek JA
    BMC Nephrol; 2023 Nov; 24(1):337. PubMed ID: 37957561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of Chronic Kidney Disease Risk Categories and Risk of Cardiovascular Disease and Total Mortality: Coronary Artery Risk Development in Young Adults Cohort.
    Choi Y; Jacobs DR; Shroff GR; Kramer H; Chang AR; Duprez DA
    J Am Heart Assoc; 2022 Nov; 11(21):e026685. PubMed ID: 36314497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988-2014.
    Ali MK; Bullard KM; Saydah S; Imperatore G; Gregg EW
    Lancet Diabetes Endocrinol; 2018 May; 6(5):392-403. PubMed ID: 29500121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population.
    Ji E; Kim YS
    Korean J Intern Med; 2016 Nov; 31(6):1120-1130. PubMed ID: 27017386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LEADER-6: Baseline renal function and associated factors in a high cardiovascular risk type 2 diabetes population.
    Satman I; R Rea R; Eriksson M; Mosenzon O; Pratley R; M Baeres F; D Ørsted D; F Mann J;
    J Diabetes Complications; 2016; 30(8):1631-1639. PubMed ID: 27320184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between water intake, chronic kidney disease, and cardiovascular disease: a cross-sectional analysis of NHANES data.
    Sontrop JM; Dixon SN; Garg AX; Buendia-Jimenez I; Dohein O; Huang SH; Clark WF
    Am J Nephrol; 2013; 37(5):434-42. PubMed ID: 23594828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Risk Models to Identify Patients at High-Risk for Severe Clinical Outcomes With Chronic Kidney Disease and Type 2 Diabetes.
    Sheer R; Nair R; Pasquale MK; Evers T; Cockrell M; Gay A; Singh R; Schmedt N
    J Prim Care Community Health; 2022; 13():21501319211063726. PubMed ID: 35068244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prevalence of CKD in Rural Canadian Indigenous Peoples: Results From the First Nations Community Based Screening to Improve Kidney Health and Prevent Dialysis (FINISHED) Screen, Triage, and Treat Program.
    Komenda P; Lavallee B; Ferguson TW; Tangri N; Chartrand C; McLeod L; Gordon A; Dart A; Rigatto C
    Am J Kidney Dis; 2016 Oct; 68(4):582-590. PubMed ID: 27257016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AWAREness of Diagnosis and Treatment of Chronic Kidney Disease in Adults With Type 2 Diabetes (AWARE-CKD in T2D).
    Chu L; Bhogal SK; Lin P; Steele A; Fuller M; Ciaccia A; Abitbol A
    Can J Diabetes; 2022 Jul; 46(5):464-472. PubMed ID: 35739044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.